Home›Companies›Healthcare›MedVector

MedVector Corp

MedVector helps clinical trial sponsors reach patients through their local physicians.

Updated Nov 10, 2026·Latest SEC filing May 6, 2026·Suggest an edit

About MedVector

MedVector is a private company based in El Segundo, California. It has reported $2,130,000 raised in three offerings on Form D since January 2022. Its chief executive is Scott Stout.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 7, 2025Oct 16, 2025amended May 6, 2026$1,005,000of $1.1M target1$1.0MOptions, SafeRule 506(b)Form D/A ↗1 earlier filing
Aug 23, 2023Nov 7, 2023$700,000of $1.2M target7$100KSecurities on exerciseRule 506(b)Form D ↗
Nov 18, 2021Jan 18, 2022$425,000of $2.0M target6$70,833Securities on exerciseRule 506(b)Form D ↗
Total, three offerings$2,130,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on MedVector's Form D filed May 6, 2026.

Dennis Patterson
Dennis Patterson
Co-founder / Advisor Hospital Systems and director
Craig Lipset
Craig Lipset
Corporate Strategy/Executive Advisor and director
Ted Barduson
Ted Barduson
Co-founder / COO and director
Scott Stout
Scott Stout
Co-founder / CEO and director
Ian Leaman
Ian Leaman
CFO / Investor and director

Sources

  1. SECMedVector Corp Form D, filed Oct 16, 2025
  2. SECMedVector Corp filing history
  3. CompanyMedVector leadership
  4. CompanyMedVector announcements